Advisory Committee on Immunization Practices: Notice of Charter Renewal, 19890 [E6-5724]

Download as PDF 19890 Federal Register / Vol. 71, No. 74 / Tuesday, April 18, 2006 / Notices Topics of the Meeting The Commission will discuss options for making longer-term recommendations on the future of the Medicaid program that ensure long-term sustainability. Issues to be addressed may include, but are not limited to: Eligibility, benefit design, and delivery; expanding the number of people covered with quality care while recognizing budget constraints; long term care; quality of care, choice, and beneficiary satisfaction; and program administration. Procedure and Agenda This meeting is open to the public. There will be a public comment period at the meeting. The Commission may limit the number and duration of oral presentations to the time available. We will request that you declare at the meeting whether or not you have any financial involvement related to any services being discussed. After the presentations and public comment period, the Commission will deliberate openly. Interested persons may observe the deliberations, but the Commission will not hear further comments during this time except at the request of the Chairperson. The Commission will also allow an open public session for any attendee to address issues specific to the topic. Authority: 5 U.S.C. App. 2, section 10(a)(1) and (a)(2). Dated: April 5, 2006. Mary M. McGeein, Deputy Assistant Secretary for Planning and Evaluation, Office of Disability, Aging and Long-Term Care. [FR Doc. E6–5722 Filed 4–17–06; 8:45 am] BILLING CODE 5150–05–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention hsrobinson on PROD1PC68 with NOTICES Advisory Committee on Immunization Practices: Notice of Charter Renewal This gives notice under the Federal Advisory Committee Act (Pub. L. 92– 463) of October 6, 1972, that the Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention, Department of Health and Human Services, has been renewed for a 2-year period through April 1, 2008. For information, contact Dr. Larry Pickering, Executive Secretary, Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention, Department of Health VerDate Aug<31>2005 15:03 Apr 17, 2006 Jkt 208001 and Human Services, 1600 Clifton Road, NE., Mailstop E05, Atlanta, Georgia 30333, telephone (404) 639–8767 or fax (404) 639–8626. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: April 12, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6–5724 Filed 4–17–06; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panels (SEP): Antimicrobial Resistance, Request for Applications (RFA) CI 06–003 In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting: Name: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Antimicrobial Resistance, RFA CI 06–003. Time and Date: 8 a.m.–5 p.m., May 10, 2006 (Closed). Place: Centers for Disease Control and Prevention, 1600 Clifton Road NE., Building 19, Room 231, Auditorium B1, Atlanta, GA 30333. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: The meeting will include the review, discussion, and evaluation of applications received in response to Antimicrobial Resistance, RFA CI 06–003. Contact Person For More Information: M. Chris Langub, PhD, Scientific Review Administrator, Office of Extramural Programs, NIOSH, CDC, 1600 Clifton Road NE, Mailstop E74, Atlanta, GA 30333, Telephone 404–498–2543. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 CDC and the Agency for Toxic Substances and Disease Registry. Dated: April 12, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6–5718 Filed 4–17–06; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Centers for Agricultural Disease and Injury Research, Education and Prevention, Program Announcement (PA) Number 06–057 In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting: Name: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Centers for Agricultural Disease and Injury Research, Education and Prevention, Program Announcement Number 06–057. Time and Date: 8 a.m.–5 p.m., May 16, 2006 (Closed). Place: Renaissance Marriott, 6th Avenue, Pittsburgh, PA 15233 telephone 412–992– 2049. Status: The meeting will be closed to the public in accordance with provisions set forth in section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: The meeting will include the review, discussion, and evaluation of applications received in response to Centers for Agricultural Disease and Injury Research, Education and Prevention, Program Announcement Number 06–057. Contact Person for More Information: Steve Olenchock, PhD, Scientific Review Administrator, National Institute for Occupational Safety and Health, CDC, 1095 Willowdale Road, MS 1119, Morgantown, WV 26505, Telephone 304–285–6271. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. E:\FR\FM\18APN1.SGM 18APN1

Agencies

[Federal Register Volume 71, Number 74 (Tuesday, April 18, 2006)]
[Notices]
[Page 19890]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-5724]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Immunization Practices: Notice of Charter 
Renewal

    This gives notice under the Federal Advisory Committee Act (Pub. L. 
92-463) of October 6, 1972, that the Advisory Committee on Immunization 
Practices, Centers for Disease Control and Prevention, Department of 
Health and Human Services, has been renewed for a 2-year period through 
April 1, 2008.
    For information, contact Dr. Larry Pickering, Executive Secretary, 
Advisory Committee on Immunization Practices, Centers for Disease 
Control and Prevention, Department of Health and Human Services, 1600 
Clifton Road, NE., Mailstop E05, Atlanta, Georgia 30333, telephone 
(404) 639-8767 or fax (404) 639-8626.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

    Dated: April 12, 2006.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
 [FR Doc. E6-5724 Filed 4-17-06; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.